Search Results - "Janetzky, Wolfgang"
-
1
BPRS domains, items and subgroups analyses, and CGI-I ratings in pooled data from non-interventional studies of aripiprazole once-monthly in schizophrenia (REACT study)
Published in BMC psychiatry (14-03-2023)“…Patients with schizophrenia may benefit from treatment with long-acting injectable (LAI) formulations of antipsychotics. Aripiprazole once-monthly (AOM) is an…”
Get full text
Journal Article -
2
Real-world effectiveness of aripiprazole once-monthly REACT study: Pooled analysis of two noninterventional studies
Published in European psychiatry (20-07-2022)“…Noninterventional naturalistic studies are an important complement to randomized controlled trials. Aripiprazole once-monthly (AOM) is an atypical…”
Get full text
Journal Article -
3
Improvement of functioning in patients with schizophrenia: real-world effectiveness of aripiprazole once-monthly (REACT study)
Published in BMC psychiatry (31-05-2023)“…Functional impairment affects many patients with schizophrenia. Treatment with the long-acting injectable antipsychotic aripiprazole once-monthly (AOM) may…”
Get full text
Journal Article -
4
The use of long-acting Aripiprazole in a multi-center, prospective, uncontrolled, open-label, cohort study in Germany: a report on global assessment of functioning and the WHO wellbeing index
Published in BMC psychiatry (22-02-2020)“…In this non-interventional study, the functionality and well-being of patients with schizophrenia with aripiprazole once-monthly (AOM) was evaluated under…”
Get full text
Journal Article -
5
Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study
Published in BMC psychiatry (14-11-2018)“…In this study, the treatment of schizophrenia patients with aripiprazole once-monthly (AOM) was evaluated under real-life conditions in a naturalistic setting…”
Get full text
Journal Article -
6
Symptomatic, functional and quality of life measures of remission in 194 outpatients with schizophrenia followed naturalistically in a 6-month, non-interventional study of aripiprazole once-monthly
Published in NPJ schizophrenia (08-11-2023)“…An important goal in the treatment of patients with schizophrenia is remission in various domains, i.e., of symptoms, psychosocial functioning and subjective…”
Get full text
Journal Article -
7
Correction to: Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study
Published in BMC psychiatry (14-12-2018)“…Following publication of the original article…”
Get full text
Journal Article -
8
Response prediction in treatment of patients with schizophrenia after switching from oral aripiprazole to aripiprazole once-monthly
Published in Schizophrenia research (01-10-2023)Get full text
Journal Article -
9
Efficacy of memantine in delaying clinical worsening in Alzheimer's disease (AD): responder analyses of nine clinical trials with patients with moderate to severe AD
Published in International journal of geriatric psychiatry (01-06-2012)“…Objective Responder analyses are of relevance to evaluate the benefits of a medical treatment. The aim of the current paper is to analyse the response of…”
Get full text
Journal Article -
10
Answer to Berghmans-GPS-11-0230 patients with Alzheimer's disease-undeserving to treat?
Published in International journal of geriatric psychiatry (01-06-2012)Get full text
Journal Article -
11
Motivational interviewing : A possibility for doctor-patient communication in schizophrenia?
Published in Nervenarzt (02-04-2019)“…Motivational interviewing (MI) has become established nowadays as an approach for a cooperative style of conversation to promote intrinsic motivation for…”
Get full text
Journal Article -
12
Motivational interviewing: Eine Möglichkeit der Arzt-Patienten-Kommunikation bei Schizophrenie?
Published in Nervenarzt (01-11-2019)“…Zusammenfassung „Motivational interviewing“ (MI; motivierende Gesprächsführung) hat sich als Ansatz für einen kooperativen Gesprächsstil zur Förderung…”
Get full text
Journal Article -
13
Measuring therapeutic efficacy in patients with Alzheimer's disease: role of instruments
Published in Dementia and geriatric cognitive disorders (01-04-2011)“…Global cognitive scales and meta-analyses thereof are used to appraise therapeutic efficacy over a broad range of disease severity. Clinically, however,…”
Get more information
Journal Article -
14
Efficacy of Memantine in delaying clinical worsening: Responder analyses in patients with moderate to severe Alzheimer's disease
Published in Alzheimer's & dementia (01-07-2011)Get full text
Journal Article -
15
Efficacy of memantine in patients with Alzheimer's disease: Meta-analyses of 9 clinical trials
Published in Alzheimer's & dementia (01-07-2011)Get full text
Journal Article -
16
P4‐223: Efficacy of memantine in patients with Alzheimer's disease: Meta‐analyses of 9 clinical trials
Published in Alzheimer's & dementia (01-07-2011)Get full text
Journal Article -
17
P4‐221: Efficacy of Memantine in delaying clinical worsening: Responder analyses in patients with moderate to severe Alzheimer's disease
Published in Alzheimer's & dementia (01-07-2011)Get full text
Journal Article -
18
Motivational interviewing : A possibility for doctor-patient communication in schizophrenia?
Published in Nervenarzt (01-11-2019)Get full text
Journal Article -
19
Efficiency of memantine - a meta-analysis of non-interventional studies in the treatment of Alzheimer's disease
Published in Alzheimer's & dementia (01-07-2011)Get full text
Journal Article -
20
P4‐237: Efficiency of memantine ‐ a meta‐analysis of non‐interventional studies in the treatment of Alzheimer's disease
Published in Alzheimer's & dementia (01-07-2011)Get full text
Journal Article